Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383710821> ?p ?o ?g. }
- W4383710821 abstract "Acute myeloid leukemia (AML) that develops along with prior or concurrent tumors without previous cyto- or radiotherapy (pc-AML) is an essential subset of AML but is often ignored and ambiguous. The biological and genetic characteristics of pc-AML remain largely unknown. Moreover, it is unclear whether pc-AML should be treated as de novo or secondary AML, whereas most clinical trials exclude it due to comorbidities. We performed a retrospective study of 50 patients with multiple neoplasms over five years. We focused on characteristics, treatment regimens, response rate, and prognosis of pc-AML, compared with therapy-related AML (tAML) and AHD-AML (AML discovered following prior hematologic disorders) as controls. We report the first detailed distribution of secondary tumors associated with hematological disorders. The incidence of pc-AML was 30% of all multiple neoplasms, and it was predominantly found in male and older participants. Nearly three-quarters of gene mutations affected epigenetic regulation and signaling pathways, and NPM1, ZRSR2, and GATA2 occurred exclusively in pc-AML. No significant differences were in CR, and pc-AML had an inferior OS similar to that of tAML and AHD-AML. More patients received hypomethylation agents (HMAs) in combination with venetoclax (HMAs + VEN) than intensive chemotherapy (IC) (65.7% vs 31.4%), and there was a trend toward improved OS in HMAs + VEN-based than in IC-based patients, whose 2-year estimated OS times were 53.6% and 35.0%, respectively. In conclusion, our results collectively support pc-AML as a biologically and genetically distinct entity with high-risk and dismal outcomes, and HMAs in combination with venetoclax-based regimens may benefit patients with pc-AML." @default.
- W4383710821 created "2023-07-11" @default.
- W4383710821 creator A5013653434 @default.
- W4383710821 creator A5021120390 @default.
- W4383710821 creator A5044216882 @default.
- W4383710821 creator A5050161425 @default.
- W4383710821 creator A5070606109 @default.
- W4383710821 date "2023-07-10" @default.
- W4383710821 modified "2023-09-26" @default.
- W4383710821 title "Analysis and clinical characteristics of acute myeloid leukemia developing with prior or concurrent tumors in non cyto- or radiotherapy exposure patients in a single center" @default.
- W4383710821 cites W1957739887 @default.
- W4383710821 cites W1965530514 @default.
- W4383710821 cites W1994791499 @default.
- W4383710821 cites W2082365047 @default.
- W4383710821 cites W2102461774 @default.
- W4383710821 cites W2107027906 @default.
- W4383710821 cites W2111724321 @default.
- W4383710821 cites W2120502315 @default.
- W4383710821 cites W2123331484 @default.
- W4383710821 cites W2128022465 @default.
- W4383710821 cites W2129338773 @default.
- W4383710821 cites W2136464910 @default.
- W4383710821 cites W2339658711 @default.
- W4383710821 cites W253205281 @default.
- W4383710821 cites W2584413057 @default.
- W4383710821 cites W2605196669 @default.
- W4383710821 cites W2783500974 @default.
- W4383710821 cites W2785262117 @default.
- W4383710821 cites W2791098750 @default.
- W4383710821 cites W2793564579 @default.
- W4383710821 cites W2793886497 @default.
- W4383710821 cites W2805581894 @default.
- W4383710821 cites W2883399820 @default.
- W4383710821 cites W2888569026 @default.
- W4383710821 cites W2889646458 @default.
- W4383710821 cites W2898096704 @default.
- W4383710821 cites W2898284215 @default.
- W4383710821 cites W2905344869 @default.
- W4383710821 cites W2941195272 @default.
- W4383710821 cites W2945338000 @default.
- W4383710821 cites W2981869008 @default.
- W4383710821 cites W2988512496 @default.
- W4383710821 cites W2997524822 @default.
- W4383710821 cites W2999417355 @default.
- W4383710821 cites W3013447738 @default.
- W4383710821 cites W3038237243 @default.
- W4383710821 cites W3048827006 @default.
- W4383710821 cites W3108408970 @default.
- W4383710821 cites W3134931765 @default.
- W4383710821 cites W4220689391 @default.
- W4383710821 cites W4223950715 @default.
- W4383710821 cites W4225845169 @default.
- W4383710821 cites W4296501741 @default.
- W4383710821 cites W4319442392 @default.
- W4383710821 doi "https://doi.org/10.1080/16078454.2023.2230738" @default.
- W4383710821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37427790" @default.
- W4383710821 hasPublicationYear "2023" @default.
- W4383710821 type Work @default.
- W4383710821 citedByCount "0" @default.
- W4383710821 crossrefType "journal-article" @default.
- W4383710821 hasAuthorship W4383710821A5013653434 @default.
- W4383710821 hasAuthorship W4383710821A5021120390 @default.
- W4383710821 hasAuthorship W4383710821A5044216882 @default.
- W4383710821 hasAuthorship W4383710821A5050161425 @default.
- W4383710821 hasAuthorship W4383710821A5070606109 @default.
- W4383710821 hasBestOaLocation W43837108211 @default.
- W4383710821 hasConcept C104317684 @default.
- W4383710821 hasConcept C126322002 @default.
- W4383710821 hasConcept C143998085 @default.
- W4383710821 hasConcept C2483381 @default.
- W4383710821 hasConcept C2776694085 @default.
- W4383710821 hasConcept C2777938653 @default.
- W4383710821 hasConcept C2778461978 @default.
- W4383710821 hasConcept C2778729363 @default.
- W4383710821 hasConcept C2779282312 @default.
- W4383710821 hasConcept C2779675984 @default.
- W4383710821 hasConcept C30481170 @default.
- W4383710821 hasConcept C509974204 @default.
- W4383710821 hasConcept C53226629 @default.
- W4383710821 hasConcept C55493867 @default.
- W4383710821 hasConcept C71924100 @default.
- W4383710821 hasConcept C86803240 @default.
- W4383710821 hasConceptScore W4383710821C104317684 @default.
- W4383710821 hasConceptScore W4383710821C126322002 @default.
- W4383710821 hasConceptScore W4383710821C143998085 @default.
- W4383710821 hasConceptScore W4383710821C2483381 @default.
- W4383710821 hasConceptScore W4383710821C2776694085 @default.
- W4383710821 hasConceptScore W4383710821C2777938653 @default.
- W4383710821 hasConceptScore W4383710821C2778461978 @default.
- W4383710821 hasConceptScore W4383710821C2778729363 @default.
- W4383710821 hasConceptScore W4383710821C2779282312 @default.
- W4383710821 hasConceptScore W4383710821C2779675984 @default.
- W4383710821 hasConceptScore W4383710821C30481170 @default.
- W4383710821 hasConceptScore W4383710821C509974204 @default.
- W4383710821 hasConceptScore W4383710821C53226629 @default.
- W4383710821 hasConceptScore W4383710821C55493867 @default.
- W4383710821 hasConceptScore W4383710821C71924100 @default.
- W4383710821 hasConceptScore W4383710821C86803240 @default.
- W4383710821 hasFunder F4320321001 @default.
- W4383710821 hasIssue "1" @default.